MLTI-03. FIRST-LINE STEREOTACTIC RADIOSURGERY COMBINED WITH SYSTEMIC TARGETED AND IMMUNE CHECKPOINT INHIBITOR THERAPY IN MELANOMA PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES

BACKGROUND: Of solid tumors, melanoma has the highest propensity for CNS spread with historic median survivals of 5–8 months following brain metastasis diagnosis. We evaluated the impact of systemic BRAF targeted and immune checkpoint inhibitor (ICI) therapies on survival outcomes in patients receiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Heumann, Thatcher, Ye, Rebecca, Wu, Peter, Habibi, Akram, Sansosti, Alexandra, Beaudreault, Cameron, Kryger, Marc, Bernstein, Kenneth, Pavlick, Anna, Kondziolka, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213436/
http://dx.doi.org/10.1093/noajnl/vdz014.062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213436/
http://dx.doi.org/10.1093/noajnl/vdz014.062

Ejemplares similares